Table 1 Summary of demographics and characteristics of patients with Behçet’s syndrome and controls without Behçet’s syndrome
Characteristics | Before propensity score matching | After propensity score matching | ||
|---|---|---|---|---|
Behçet’s syndrome (n = 1625) | Behçet’s syndrome (n = 1554) | Control (n = 3108) | Standardized mean difference | |
Sex, n (%) | 0.04 | |||
Female | 942 (58.0) | 901 (58.0) | 1735 (56.0) | |
Male | 683 (42.0) | 653 (42.0) | 1373 (44.0) | |
Age group, n (%), years | 0.001 | |||
18–44 | 1131 (69.6) | 1064 (68.5) | 2130 (68.5) | |
≧45 | 494 (30.4) | 490 (31.5) | 978 (31.5) | |
Age, mean ± SD, years | 38.8 ± 11.9 | 39.2 ± 12.0 | 39.1 ± 12.2 | 0.008 |
Comorbidities, n (%) | ||||
Diabetes | 39 (2.4) | 39 (2.5) | 88 (2.8) | -0.020 |
Hypertension | 104 (6.4) | 103 (6.6) | 211 (6.7) | -0.006 |
Hyperlipidemia | 40 (2.5) | 40 (2.6) | 98 (3.1) | -0.035 |
Chronic kidney disease | 21 (1.3) | 21 (1.4) | 41 (1.3) | 0.003 |
COPD | 21 (1.3) | 21 (1.4) | 40 (1.3) | 0.006 |
Medications, n (%) | ||||
NSAID | 465 (28.6) | 405 (26.1) | 802 (25.8) | 0.006 |
Corticosteroid | 589 (36.3) | 520 (33.5) | 1048 (33.7) | -0.005 |
Statin | 16 (1.0) | 16 (1.0) | 46 (1.4) | -0.04 |
Aspirin | 37 (2.3) | 33 (2.1) | 67 (2.2) | -0.002 |